유럽 ​​생식기 사마귀 시장 – 2029년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Pharmaceutical Europe Genital Warts Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​생식기 사마귀 시장 – 2029년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Europe
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60
지금 구매 지금 구매

Europe Genital Warts Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
 2022 –2029
Diagram 시장 규모(기준 연도)
 USD 1,519.14 Million
Diagram 시장 규모(예측 연도)
 USD 2,552.19 Million
Diagram 연평균 성장률
 %
Diagram주요 시장 플레이어
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
잠금 해제 요청

>유럽 ​​생식기 사마귀 시장, 형태(콜리플라워 유사, 매끈한 유두종, 각질성 및 편평한 사마귀), 유형(예방, 진단, 치료), 원인(HPV 6, HPV 11, 기타), 위치(외음부, 자궁경부, 요도, 항문, 음낭), 성별(남성 및 여성), 복용량(크림, 젤, 연고, 근육 주사 및 기타), 최종 사용자(병원, 홈 케어, 전문 클리닉, 기타), 유통 채널(병원 약국, 온라인 약국, 소매 약국) - 2029년까지의 산업 동향 및 예측.

유럽 ​​생식기 사마귀 시장

유럽 ​​생식기 사마귀 시장 분석 및 규모

유럽 ​​생식기 사마귀 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 생식기 사마귀는 인간 유두종 바이러스(HPV)로 인해 발생합니다. HPV에는 약 30-40가지 균주가 있습니다. 세계보건기구(WHO)의 2019년 기록에 따르면 전 세계적으로 매일 100만 건 이상의 성병(STI)이 발생하고 2억 9천만 명 이상의 여성이 인간 유두종 바이러스(HPV)에 감염됩니다. 사마귀가 재발하면 보다 진보된 치료에 대한 수요가 증가합니다. 사마귀에 대한 여러 가지 치료법이 있습니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

 Data Bridge Market Research는 2022-2029년 예측 기간 동안 유럽 생식기 사마귀 시장의 성장률을 분석합니다. 유럽 생식기 사마귀 시장의 예상 CAGR은 언급된 예측 기간 동안 약 6.70%인 경향이 있습니다. 이 시장은 2021년에 1,519.14백만 달러로 평가되었으며 2029년까지 2552.19백만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

생식기 사마귀는 가장 재발하는 성병 중 하나입니다. HPV는 생식기 사마귀를 유발하는 바이러스입니다. 사람들은 적어도 한 가지 유형의 인간 유두종 바이러스(HPV)에 감염될 가능성이 높습니다. 생식기 사마귀는 남성과 여성 환자의 생식기 부위에 있는 대부분의 습한 조직에 영향을 미칩니다. 생식기 감염은 무증상이지만 증상이 나타나기 때문에 생식기 사마귀로 인식되는 경우가 많습니다. 미국에서 성적으로 활동적인 남성과 여성의 약 1%가 생식기 사마귀를 앓고 있는 것으로 추산됩니다.

유럽 ​​생식기 사마귀 시장 범위 및 세분화

보고서 메트릭

세부

예측 기간

2022년부터 2029년까지

기준 연도

2021

역사적 연도

2020 (2014-2019로 사용자 정의 가능)

양적 단위

매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨

다루는 세그먼트

형태(콜리플라워 유사, 매끈한 유두종, 각질성, 편평한 사마귀), 유형(예방, 진단, 치료), 원인(HPV 6, HPV 11, 기타), 위치(외음부, 자궁경부, 요도, 항문, 음낭), 성별(남성 및 여성), 복용량(크림, 젤, 연고, 근육 내 및 기타), 최종 사용자(병원, 홈케어, 전문 병원, 기타), 유통 채널(병원 약국, 온라인 약국, 소매 약국)

적용 국가

독일, 프랑스, ​​이탈리아, 벨기에, 스페인, 네덜란드, 러시아, 스위스, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드, 유럽의 나머지 지역

시장 참여자 포함

Bausch Health Companies Inc(캐나다), Merck & Co., Inc(미국), Taro Pharmaceutical Industries Ltd(이스라엘), CryoIQ(스웨덴), GSK plc(영국), BioNTech SE(독일), Serum Institute of India Pvt. Ltd(인도), Fotona(미국), Orgenesis Inc(미국), Perrigo Company plc(아일랜드)

시장 기회
  • 시장 참여자들이 출시한 새로운 치료법
  • 소매 약국에 대한 수요 증가
  • 연구 개발 증가

유럽 ​​생식기 사마귀 시장 동향

운전자

  • 성병 감염 증가

성병(STI)의 유병률이 증가함에 따라 시장 성장이 촉진될 것으로 예상됩니다. 2021년 말에 전 세계적으로 약 3,840만 명이 STI를 앓고 있었습니다. WHO 2019에 따르면 전 세계적으로 매일 100만 건 이상의 성병(STI)이 발생하고 2억 9,000만 명 이상의 여성이 인유두종 바이러스(HPV)에 감염되었습니다. 따라서 이러한 감염 건수가 증가함에 따라 시장 성장이 촉진됩니다.

  • 자궁경부암 발병률 증가

자궁경부암 발병률은 많은 저개발 국가에서 높으며, 자궁경부암 사례의 80% 이상이 진단됩니다. WHO에 따르면 자궁경부암은 여성에게 가장 흔한 악성 종양이며 전 세계적으로 암 관련 사망의 두 번째 원인으로, 매년 30만 명 이상이 사망합니다. 이로 인해 시장 성장이 촉진됩니다.

기회

  • 시장 참여자들이 출시한 새로운 치료법

시장 참여자들은 예측 기간 동안 유럽 생식기 사마귀 시장의 성장을 증가시킬 것으로 예상되는 새로운 치료 플랫폼을 출시하는 데 참여하고 있습니다. 예를 들어, 2019년에 원격 의료 서비스의 글로벌 공급업체인 GenieMD는 원격 의료 앱 iVisit을 출시했는데, 이를 통해 의사와의 가상 방문을 통해 생식기 사마귀 환자의 진단 및 치료가 가능해졌습니다.

  • 소매 약국에 대한 수요 증가

자궁경부암의 증가로 인해 소매 약국을 통한 약물 배달이 이루어졌고, 고도로 발달한 국가에서는 소매 약국의 수가 급증했습니다. 또한 환자들은 약물을 구매하기 위해 소매 약국을 선택하는데, 이는 쉽게 접근할 수 있기 때문입니다.

  • 연구 개발 증가

Growing R&D in order to develop treatment for genital warts is projected to increase the growth of the global genital warts market during the forecast period. For instance, University of Pretoria, South Africa, in collaboration with University of Stellenbosch, South Africa, are currently conducting clinical trials to study the effectiveness of human papillomavirus (HPV) vaccine against the existence of genital warts. The study was started in the year 2018 and is projected to be completed by 2023. At present, the study is in the Phase III clinical trial.

 Restraints/Challenges

  • Lack of Awareness

Even though the occurrence of genital warts is high among the population, but its diagnosis rate is still low. The low diagnostic rate of genital warts is because of the lack of awareness about the infection, which may impede the genital warts market growth. For instance, as per the Health Protection report in 2018, the diagnosis rate of genital warts in England among girls aged 15 to 17 decreased by 92% compared to 2014. Furthermore, existing treatment procedures are often painful or invasive and can have unfavorable outcomes such as scarring or dyspigmentation, often requiring frequent visits. This results in a reduction in the diagnostic rate, likely restraining the genital warts market.

  • High Cost

The huge expenditure associated with infection drugs, gels, or severe treatment procedures hamper market growth.

This Europe genital warts market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe genital warts market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Europe Genital Warts Market       

COVID-19 pandemic has benefited the global human papillomavirus infection drugs market positively. Even though there was lockdown and many of the tasks were in consideration with COVID-19, most healthcare workers are carrying out their tasks, and companies are spending greatly in vaccine development for HPV.

The bigger population demand for HPV vaccine is likely to boost the market during a pandemic. Vaccine manufacturers and other scientists are working continuously on the development of HPV vaccines as well as COVID viral symptoms, which is predicted to boost the market in the next years.

Europe Genital Warts Market Scope

유럽 ​​생식기 사마귀 시장은 형태, 예방, 원인, 위치, 성별, 복용량, 유통 채널 및 최종 사용자를 기준으로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.

형태

  • 콜리플라워와 같은
  • 매끄러운 유두종
  • 각질화
  • 편평한 사마귀

방지

  • 방지
  • 진단
  • 치료

원인

  • 인유두종바이러스 6형
  • 인유두종바이러스 11
  • 기타

위치

  • 외음부
  • 자궁경부 자궁
  • 요도
  • 항문
  • 음낭

성별

  • 남성
  • 여성

복용량

  • 크림
  • 젤라틴
  • 연고
  • 근육내 주사
  • 기타

최종 사용자

  • 병원
  • 홈케어
  • 전문 클리닉
  • 기타

유통 채널

  • 병원 약국
  • 온라인 약국
  • 소매 약국

유럽 ​​생식기 사마귀 시장 지역 분석/통찰력

유럽 ​​생식기 사마귀 시장을 분석하고, 위에 언급된 대로 형태, 예방, 원인, 위치, 성별, 복용량, 유통 채널 및 최종 사용자별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

유럽 ​​생식기 사마귀 시장 보고서에서 다루는 주요 국가  는 독일, 프랑스, ​​이탈리아, 벨기에, 스페인, 네덜란드, 러시아, 스위스, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드 및 기타 유럽 국가입니다.

독일은 주요 시장 참여자들의 존재와 지역 내 기술 진보의 증가로 인해 시장을 지배할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 유럽 생식기 사마귀 시장 점유율 분석

유럽 ​​생식기 사마귀 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 유럽 생식기 사마귀 시장과 관련된 회사의 초점에만 관련이 있습니다.

유럽 ​​생식기 사마귀 시장에서 활동하는 주요 기업은 다음과 같습니다.

  • Bausch Health Companies Inc(캐나다)
  • 머크앤코(미국)
  • 타로제약산업(이스라엘)
  • CryoIQ(스웨덴)
  • GSK plc (영국)
  • BioNTech SE(독일)
  • Serum Institute of India Pvt. Ltd(인도)
  • 포토나(미국)
  • 오제네시스 주식회사(미국)
  • Perrigo Company plc (아일랜드)

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW OF THE EUROPE GENITAL WARTS MARKET
    4. CURRENCY AND PRICING
    5. LIMITATIONS
    6. MARKETS COVERED
  2. Europe GENITAL WARTS market: SEGMENTATION
    1. MARKETS COVERED
    2. GEOGRAPHICAL SCOPE
    3. YEARS CONSIDERED FOR THE STUDY
    4. DBMR TRIPOD DATA VALIDATION MODEL
    5. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
    6. MULTIVARIATE MODELLING
    7. DISTRIBUTION CHANNEL LIFELINE CURVE
    8. DBMR MARKET POSITION GRID
    9. VENDOR SHARE ANALYSIS
    10. MARKET END USER COVERAGE GRID
    11. SECONDARY SOURCES
    12. ASSUMPTIONS
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. Porter's Five Forces Model
  6. PESTEL Analysis
  7. Pipeline analysis: Europe genital warts market
  8. Europe GENITAL WARTS market: regulations
    1. CANADA
    2. U.S.
    3. EUROPE
    4. JAPAN
    5. MALAYSIA
    6. VIETNAM
    7. SOUTH AMERICA
  9. Market Overview
    1. drivers
      1. RISE IN PREVALENCE OF SEXUALLY TRANSMITTED DISEASES AND HUMAN PAPILLOMAVIRUS (HPV) VIRUS
      2. RISE OF MALE POPULATION
      3. RISE IN GOVERNMENT INITIATIVES AND AWARENESS PROGRAMMES
      4. RISE IN CLINICAL TRIALS
      5. RISE IN HEALTHCARE EXPENDITURE
    2. RESTRAINTS
      1. RISE IN COST FOR GENITAL WARTS TREATMENT
      2. SIDE EFFECTS OBSERVED WHILE UNDERGOING THE TREATMENT FOR GENITAL WARTS
      3. LACK OF PATIENT AND CONSUMER AWARENESS
      4. LESS DIAGNOSTIC RATE
    3. opportunities
      1. USE OF LASER TREATMENT AND CRYOTHERAPY FOR TREATMENT OF GENITAL WARTS.
      2. STRATEGIC INITIATIVES BY MARKET PLAYERS.
      3. RESEARCH AND DEVELOPMENT FOR GENERIC MEDICATIONS
    4. CHALLENGES
      1. RISE IN PRODUCT RECALL.
      2. PATIENT COMPLIANCE REGARDING THE USE OF VACCINES AND OINTMENTS FOR TREATMENT OF GENITAL WARTS
  10. IMPACT OF COVID-19 ON EUROPE GENITAL WARTS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS BY MANUFACTURERS
    5. CONCLUSION
  11. Europe GENITAL WARTS MARKET, BY MORPHOLOGY
    1. overview
    2. Cauliflower-Like
    3. Smooth Papular
    4. Keratotic
    5. Flat Warts
  12. Europe GENITAL WARTS MARKET, BY type
    1. overview
    2. prevention
    3. diagnostic
      1. hpv test
      2. pap test
    4. treatment
      1. Pharmacological Treatment
        1. Imiquimod
        2. Podophyllin and Podofilox
        3. Trichloroacetic Acid
        4. Sinecatechins
        5. others
      2. non- Pharmacological Treatment
        1. Cryotherapy
        2. Electrocautery
        3. Laser Treatment
        4. Surgical Excision
      3. Gardasil
      4. cervarix
  13. Europe GENITAL WARTS MARKET, BY cause
    1. overview
    2. HPV 6
    3. HPV 11
    4. Others
  14. Europe GENITAL WARTS MARKET, BY Location
    1. overview
    2. Vulva
    3. Cervix Uteri
    4. Urethra
    5. anus
    6. Scrotum
  15. Europe GENITAL WARTS MARKET, BY gender
    1. overview
    2. female
    3. male
  16. Europe GENITAL WARTS MARKET, BY dosage
    1. overview
    2. cream
    3. gel
    4. ointment
    5. Intramuscularly
    6. others
  17. Europe GENITAL WARTS MARKET, BY end user
    1. overview
    2. Hospitals
    3. Diagnostic Centers
    4. Surgical Centers
    5. Ambulatory Surgical Centers
    6. others
  18. Europe GENITAL WARTS MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. Pharmacy Stores
    4. others
  19. EUROPE Genital warts market, by region
    1. europe
      1. GERMANY
      2. FRance
      3. U.K.
      4. italy
      5. spain
      6. NETHERLANDS
      7. Russia
      8. Switzerland
      9. Turkey
      10. Austria
      11. NORWAY
      12. HUNGARY
      13. LITHUANIA
      14. IRELAND
      15. POLAND
      16. REST OF Europe
  20. Europe Genital Warts Market: COMPANY landscape
    1. company share analysis: Europe
  21. Swot analysis
  22. company profile
    1. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. GlaxoSmithKline plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. bausch health companies inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. product portfolio
      5. RECENT DEVELOPMENTS
    4. ANI PHARMACEUTICALS, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. BioNTech SE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. product portfolio
      5. RECENT DEVELOPMENTS
    6. cassiopea, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. cryoconcepts lp
      1. COMPANY SNAPSHOT
      2. product portfolio
      3. RECENT DEVELOPMENT
    8. CRYOIQ
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. CryoSurgery, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. edge pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. FOTONA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. glenmark pharmaceutical inc., usa (a subsidiary of glenmark Pharmaceuticals Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. novan, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. ORGENESIS INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    15. PERRIGO COMPANY PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    16. serum institute of india pvt. ltd.
      1. COMPANY SNAPSHOT
      2. product portfolio
      3. RECENT DEVELOPMENT
    17. Taro Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    18. verrica pharmaceuticals
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. product portfolio
      4. RECENT DEVELOPMENTS
  23. questionnaire
  24. related reports

표 목록

TABLE 1 Europe genital warts Market, pipeline analysis

TABLE 2 Europe GENITAL WARTS Market, By morphology, 2019-2028 (USD MILLION)

TABLE 3 Europe CAULIFLOWER-LIKE in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 4 Europe smooth papular in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 5 Europe keratotic in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 6 Europe Flat Warts in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 7 Europe GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 8 Europe prevention In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 9 Europe diagnostic in GENITAL WARTS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 10 Europe diagnostic In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 11 Europe treatment in GENITAL WARTS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 12 Europe treatment In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 13 Europe pharmacological treatment In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 14 Europe non- pharmacological treatment In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 15 Europe TREATMENT In GENITAL WARTS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 16 Europe GENITAL WARTS Market, By cause, 2019-2028 (USD MILLION)

TABLE 17 Europe HPV 6 In GENITAL WARTS MARKET, By region, 2019-2028 (USD MILLION)

TABLE 18 Europe HPV 11 In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 19 Europe others In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 20 Europe GENITAL WARTS MARKET, By Location, 2019-2028 (USD MILLION)

TABLE 21 Europe vulva In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 22 Europe Cervix Uteri In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 23 Europe urethra In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 24 Europe ANUS In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 25 Europe Scrotum In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 26 Europe GENITAL WARTS MARKET, By gender, 2019-2028 (USD MILLION)

TABLE 27 Europe female In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 28 Europe male In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 29 Europe GENITAL WARTS MARKET, By Dosage, 2019-2028 (USD MILLION)

TABLE 30 Europe cream In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 31 Europe gel In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 32 Europe ointment In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 33 Europe intramuscularly In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 34 Europe others In GENITAL WARTS MARKET, By REGION, 2019-2028 (USD MILLION)

TABLE 35 Europe GENITAL WARTS MARKET, By end user, 2019-2028 (USD MILLION)

TABLE 36 Europe HOSPITALS in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 37 Europe diagnostic centers in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 38 Europe surgical centers in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 39 Europe ambulatory surgical centers in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 40 Europe others in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 41 Europe GENITAL WARTS MARKET, By distribution channel 2019-2028 (USD MILLION)

TABLE 42 Europe direct tender in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 43 Europe pharmacy stores in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 44 Europe others in GENITAL WARTS MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 45 europe GENITAL WARTS MARKET, By COUNTRY, 2019-2028 (USD million)

TABLE 46 Europe GENITAL WARTS MARKET, By MORPHOLOGY, 2019-2028 (USD MILLION)

TABLE 47 Europe GENITAL WARTS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 Europe Diagnostic in GENITAL WARTS MARKET, by TYPE, 2019-2028 (USD MILLION)

TABLE 49 Europe Treatment in GENITAL WARTS MARKET, By Type, 2019-2028 (USD MILLION)

TABLE 50 Europe PHARMACOLOGICAL TREATMENT in GENITAL WARTs Market, By Type, 2019-2028 (USD MILLION)

TABLE 51 Europe prevention GENITAL WARTs Market, By TREATMENT, 2019-2028 (USD MILLION)

TABLE 52 europe GARDASIL GENITAL WARTS MARKET, By COUNTRY, 2019-2028 (USD million)

TABLE 53 europe CERVARIX GENITAL WARTS MARKET, By COUNTRY, 2019-2028 (USD million)

TABLE 54 Europe Non-Pharmacological Treatment in GENITAL WARTs Market, By Type, 2019-2028 (USD MILLION)

TABLE 55 Europe GENITAL WARTs Market, BY CAUSe, 2019-2028 (USD MILLION)

TABLE 56 Europe GENITAL WARTs Market, BY LOCATION, 2019-2028 (USD MILLION)

TABLE 57 Europe GENITAL WARTs Market, BY gender, 2019-2028 (USD MILLION)

TABLE 58 Europe GENITAL WARTs Market, BY Dosage, 2019-2028 (USD MILLION)

TABLE 59 Europe GENITAL WARTs Market, BY end user, 2019-2028 (USD MILLION)

TABLE 60 Europe GENITAL WARTs Market, BY Distribution Channel, 2019-2028 (USD MILLION)

TABLE 61 Germany genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 62 Germany genital warts Market, By type, 2019-2028 (USD MILLION)

TABLE 63 Germany Diagnostic in genital warts Market, By Type, 2019-2028 (USD MILLION)

TABLE 64 Germany Treatment in genital warts MARKET, BY Type, 2019-2028 (USD MILLION)

TABLE 65 Germany Pharmacological Treatment in genital warts Market, By Type, 2019-2028 (USD MILLION)

TABLE 66 Germany genital warts market, by TREATMENT, 2019-2028 (USD MILLION)

TABLE 67 Germany Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 68 Germany genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 69 Germany genital warts market, by location, 2019-2028 (USD MILLION)

TABLE 70 Germany genital warts MARKET, BY gender, 2019-2028 (USD MILLION)

TABLE 71 Germany genital warts MARKET, BY Dosage, 2019-2028 (USD MILLION)

TABLE 72 Germany genital warts MARKET, BY end user, 2019-2028 (USD MILLION)

TABLE 73 Germany genital warts market, by Distribution Channel, 2019-2028 (USD MILLION)

TABLE 74 France genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 75 France genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 76 France Diagnostic IN genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 77 France Treatment IN genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 78 France Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 79 France genital warts market, by Treatment, 2019-2028 (USD MILLION)

TABLE 80 France treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 81 France genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 82 France genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 83 France genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 84 France genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 85 France genital warts market, by end user, 2019-2028 (USD MILLION)

TABLE 86 France genital warts market, by Distribution Channel, 2019-2028 (USD MILLION)

TABLE 87 u.K. genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 88 u.K. genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 89 u.K. Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 90 u.K. Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 91 u.K. pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 92 u.K. genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 93 u.K. Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 94 u.K. genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 95 u.K. genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 96 u.K. genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 97 u.K. genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 98 u.K. genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 99 u.K. genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 100 ITALY GENITAL warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 101 ITALY GENITAL warts Market, By type, 2019-2028, (USD Million)

TABLE 102 ITALY GENITAL warts Market, By Diagnostics type, 2019-2028, (USD Million)

TABLE 103 ITALY treatment in GENITAL warts Market, By type, 2019-2028, (USD Million)

TABLE 104 ITALY Pharmacological in GENITAL warts Market, By treatment, 2019-2028, (USD Million)

TABLE 105 ITALY GENITAL warts Market, By treatment, 2019-2028, (USD Million)

TABLE 106 ITALY Non-Pharmacological Treatment in GENITAL warts Market, By treatment, 2019-2028, (USD Million)

TABLE 107 ITALY GENITAL warts Market, By cause, 2019-2028, (USD Million)

TABLE 108 ITALY GENITAL warts Market, By Location, 2019-2028, (USD Million)

TABLE 109 ITALY GENITAL warts Market, By gender, 2019-2028, (USD Million)

TABLE 110 ITALY GENITAL warts Market, By Dosage, 2019-2028, (USD Million)

TABLE 111 ITALY GENITAL warts Market, By END USER, 2019-2028, (USD Million)

TABLE 112 ITALY GENITAL warts Market, By Distribution Channel, 2019-2028, (USD Million)

TABLE 113 Spain Europe genital warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 114 Spain genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 115 Spain Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 116 Spain Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 117 Spain pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 118 Spain genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 119 Spain Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 120 Spain genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 121 Spain genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 122 Spain genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 123 Spain genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 124 Spain genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 125 Spain genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 126 Netherlands genital warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 127 Netherlands genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 128 Netherlands Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 129 Netherlands Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 130 Netherlands pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 131 Netherlands genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 132 Netherlands Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 133 Netherlands genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 134 Netherlands genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 135 Netherlands genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 136 Netherlands genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 137 Netherlands genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 138 Netherlands genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 139 Russia genital warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 140 Russia genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 141 Russia Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 142 Russia Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 143 Russia pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 144 Russia genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 145 Russia Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 146 Russia genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 147 Russia genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 148 Russia genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 149 Russia genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 150 Russia genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 151 Russia genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 152 Switzerland Europe genital warts Market, By morphology, 2019-2028 (USD MILLION)

TABLE 153 Switzerland genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 154 Switzerland Diagnostics in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 155 Switzerland Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 156 Switzerland pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 157 Switzerland genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 158 Switzerland Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 159 Switzerland genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 160 Switzerland genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 161 Switzerland genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 162 Switzerland genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 163 Switzerland genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 164 Switzerland genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 165 TURKEY GENITAL warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 166 TURKEY GENITAL warts Market, By type, 2019-2028 (USD MILLION)

TABLE 167 TURKEY Diagnostic in genital warts Market, By Type, 2019-2028 (USD MILLION)

TABLE 168 TURKEY Treatment in genital warts MARKET, BY Type, 2019-2028 (USD MILLION)

TABLE 169 TURKEY Pharmacological Treatment in genital warts Market, By Type, 2019-2028 (USD MILLION)

TABLE 170 TURKEY Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 171 TURKEY genital warts market, by TREATMENT, 2019-2028 (USD MILLION)

TABLE 172 TURKEY GENITAL warts market, by cause, 2019-2028 (USD MILLION)

TABLE 173 TURKEY GENITAL warts market, by location, 2019-2028 (USD MILLION)

TABLE 174 TURKEY GENITAL warts MARKET, BY gender, 2019-2028 (USD MILLION)

TABLE 175 TURKEY GENITAL warts MARKET, BY Dosage, 2019-2028 (USD MILLION)

TABLE 176 TURKEY GENITAL warts MARKET, BY end user, 2019-2028 (USD MILLION)

TABLE 177 TURKEY GENITAL warts market, by Distribution Channel, 2019-2028 (USD MILLION)

TABLE 178 Austria genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 179 Austria genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 180 AUSTRIA Diagnostic IN genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 181 AUSTRIA Treatment IN genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 182 AUSTRIA Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 183 AUSTRIA genital warts market, by Treatment, 2019-2028 (USD MILLION)

TABLE 184 AUSTRIA treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 185 AUSTRIA genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 186 AUSTRIA genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 187 AUSTRIA genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 188 AUSTRIA genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 189 AUSTRIA genital warts market, by end user, 2019-2028 (USD MILLION)

TABLE 190 AUSTRIA genital warts market, by Distribution Channel, 2019-2028 (USD MILLION)

TABLE 191 Norway genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 192 Norway genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 193 Norway Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 194 Norway Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 195 Norway pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 196 Norway genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 197 Norway Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 198 Norway genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 199 Norway genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 200 Norway genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 201 Norway genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 202 Norway genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 203 Norway genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 204 Hungary genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 205 Hungary genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 206 Hungary Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 207 Hungary Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 208 Hungary pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 209 Hungary genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 210 Hungary Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 211 Hungary genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 212 Hungary genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 213 Hungary genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 214 Hungary genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 215 Hungary genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 216 Hungary genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 217 Lithuania genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 218 Lithuania genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 219 Lithuania Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 220 Lithuania Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 221 Lithuania pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 222 Lithuania genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 223 Lithuania Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 224 Lithuania genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 225 Lithuania genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 226 Lithuania genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 227 Lithuania genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 228 Lithuania genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 229 Lithuania genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 230 Ireland genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 231 Ireland genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 232 Ireland Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 233 Ireland Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 234 Ireland pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 235 Ireland genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 236 Ireland Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 237 Ireland genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 238 Ireland genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 239 Ireland genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 240 Ireland genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 241 Ireland genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 242 Ireland genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 243 Poland genital warts market, by morphology, 2019-2028 (USD MILLION)

TABLE 244 Poland genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 245 Poland Diagnostic in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 246 Poland Treatment in genital warts market, by type, 2019-2028 (USD MILLION)

TABLE 247 Poland pharmacological treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 248 Poland genital warts market, by treatment, 2019-2028 (USD MILLION)

TABLE 249 Poland Non-Pharmacological Treatment in genital warts market, by Type, 2019-2028 (USD MILLION)

TABLE 250 Poland genital warts market, by cause, 2019-2028 (USD MILLION)

TABLE 251 Poland genital warts market, by LOCATION, 2019-2028 (USD MILLION)

TABLE 252 Poland genital warts market, by gender, 2019-2028 (USD MILLION)

TABLE 253 Poland genital warts market, by Dosage, 2019-2028 (USD MILLION)

TABLE 254 Poland genital warts market, by End user, 2019-2028 (USD MILLION)

TABLE 255 Poland genital warts MARKET, By Distribution Channel, 2019-2028 (USD MILLION)

TABLE 256 REST OF europe Europe genital warts Market, By morphology, 2019-2028 (USD MILLION)

그림 목록

FIGURE 1 Europe genital warts market: segmentation

FIGURE 2 Europe genital warts MARKET: data triangulation

FIGURE 3 EUROPE genital warts MARKET: DROC ANALYSIS

FIGURE 4 Europe genital warts MARKET: Europe VS REGIONAL ANALYSIS

FIGURE 5 Europe genital warts MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe genital warts MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe genital warts MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE GENITAL WARTS MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 Europe genital warts MARKET: MARKET end user COVERAGE GRID

FIGURE 10 EUROPE genital warts MARKET: SEGMENTATION

FIGURE 11 RISE OF MALE POPULATION is expected to drive the Europe genital warts MARKET in the forecast period of 2021 to 2028

FIGURE 12 cauliflower-like segment is expected to account for the largest share of the Europe genital warts market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTs, OPPORTUNITIES AND CHALLENGES OF EUROPE genital warts MARKET

FIGURE 14 PREVALENCE OF SEXUALLY TRANSMITTED DISEASES IN THE U.S., AUSTRALIA AND CANADA

FIGURE 15 INFECTION RATE OF SEXUALLY TRANSMITTED DISEASES (STDS) IN THE FOLLOWING COUNTRIES

FIGURE 16 Europe GENITAL WARTS MARKET: BY morphology, 2020

FIGURE 17 Europe GENITAL WARTS MARKET: BY morphology, 2021-2028 (USD MILLION)

FIGURE 18 Europe GENITAL WARTS MARKET: BY morphology, CAGR (2021-2028)

FIGURE 19 Europe GENITAL WARTS MARKET: BY morphology, LIFELINE CURVE

FIGURE 20 Europe GENITAL WARTS MARKET: BY type, 2020

FIGURE 21 Europe GENITAL WARTS MARKET: BY type, 2021-2028 (USD MILLION)

FIGURE 22 Europe GENITAL WARTS MARKET: BY type, CAGR (2021-2028)

FIGURE 23 Europe GENITAL WARTS MARKET: BY type, LIFELINE CURVE

FIGURE 24 Europe GENITAL WARTS market: BY cause, 2020

FIGURE 25 Europe GENITAL WARTS market: BY cause, 2021-2028 (USD MILLION)

FIGURE 26 Europe GENITAL WARTS market: BY cause, CAGR (2021-2028)

FIGURE 27 Europe GENITAL WARTS market: BY cause, LIFELINE CURVE

FIGURE 28 Europe GENITAL WARTS MARKET: BY Location 2020

FIGURE 29 Europe GENITAL WARTS MARKET: BY Location 2021-2028 (USD MILLION)

FIGURE 30 Europe GENITAL WARTS MARKET: BY Location CAGR (2021-2028)

FIGURE 31 Europe GENITAL WARTS MARKET: BY Location, LIFELINE CURVE

FIGURE 32 Europe GENITAL WARTS MARKET: BY Gender 2020

FIGURE 33 Europe GENITAL WARTS MARKET: BY Gender 2021-2028 (USD MILLION)

FIGURE 34 Europe GENITAL WARTS MARKET: BY Gender CAGR (2021-2028)

FIGURE 35 Europe GENITAL WARTS MARKET: BY Gender, LIFELINE CURVE

FIGURE 36 Europe GENITAL WARTS MARKET: BY Dosage 2020

FIGURE 37 Europe GENITAL WARTS MARKET: BY Dosage 2021-2028 (USD MILLION)

FIGURE 38 Europe GENITAL WARTS MARKET: BY Dosage CAGR (2021-2028)

FIGURE 39 Europe GENITAL WARTS MARKET: BY Dosage, LIFELINE CURVE

FIGURE 40 Europe GENITAL WARTS MARKET: BY END USER, 2020

FIGURE 41 Europe GENITAL WARTS MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 42 Europe GENITAL WARTS MARKET: BY END USER, CAGR (2021-2028)

FIGURE 43 Europe GENITAL WARTS MARKET: BY END USER, LIFELINE CURVE

FIGURE 44 Europe GENITAL WARTS MARKET: BY distribution channel, 2020

FIGURE 45 Europe GENITAL WARTS MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 46 Europe GENITAL WARTS MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 47 Europe GENITAL WARTS MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 48 Europe EUROPE GENITAL WARTS MARKET: SNAPSHOT (2020)

FIGURE 49 Europe EUROPE GENITAL WARTS MARKET: BY COUNTRY (2020)

FIGURE 50 Europe EUROPE GENITAL WARTS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 51 Europe EUROPE GENITAL WARTS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 52 Europe EUROPE GENITAL WARTS MARKET: BY MORPHOLOGY (2021-2028)

FIGURE 53 Europe Genital Warts Market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Europe genital warts market size will be worth USD 2552.19 million by 2029.
The growth rate of the Europe genital warts market is 6.70%.
The increasing prevalence of sexually transmitted infections & rising incidence of cervical cancer are the growth drivers of the Europe genital warts market.
Morphology, prevention, cause, location, gender, dosage, distribution channel and end-user are the factors on which the Europe genital warts market research is based.
Major companies in the Europe genital warts market are Bausch Health Companies Inc (Canada), Merck & Co., Inc (U.S.), Taro Pharmaceutical Industries Ltd (Israel), CryoIQ (Sweden), GSK plc (U.K.), BioNTech SE (Germany), Serum Institute of India Pvt. Ltd (India), Fotona (U.S.), Orgenesis Inc (U.S.) and Perrigo Company plc (Ireland).

관련 페이지 탐색

Banner